Stockreport

Spyre Therapeutics Announces Poster Presentations at United European Gastroenterology Week (UEGW) 2025 [Yahoo! Finance]

Spyre Therapeutics, Inc.  (SYRE) 
PDF clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflamma [Read more]